CA2211450A1 - Traitement de la neuropathie diabetique - Google Patents

Traitement de la neuropathie diabetique

Info

Publication number
CA2211450A1
CA2211450A1 CA002211450A CA2211450A CA2211450A1 CA 2211450 A1 CA2211450 A1 CA 2211450A1 CA 002211450 A CA002211450 A CA 002211450A CA 2211450 A CA2211450 A CA 2211450A CA 2211450 A1 CA2211450 A1 CA 2211450A1
Authority
CA
Canada
Prior art keywords
insulin
treatment
cream
diabetic
topical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002211450A
Other languages
English (en)
Inventor
Paul Zev Zimmet
Roderick Alan Westerman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cortecs Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2211450A1 publication Critical patent/CA2211450A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Dispersion Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention se rapporte à l'utilisation topique de l'insuline pour le traitement d'une neuropathie diabétique chez un patient.
CA002211450A 1995-02-02 1996-02-01 Traitement de la neuropathie diabetique Abandoned CA2211450A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPN0892 1995-02-02
AUPN0892A AUPN089295A0 (en) 1995-02-02 1995-02-02 Treatment of diabetic neuropathy

Publications (1)

Publication Number Publication Date
CA2211450A1 true CA2211450A1 (fr) 1996-08-08

Family

ID=3785252

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002211450A Abandoned CA2211450A1 (fr) 1995-02-02 1996-02-01 Traitement de la neuropathie diabetique

Country Status (8)

Country Link
EP (1) EP0808170A1 (fr)
JP (1) JPH11502513A (fr)
KR (1) KR19980701896A (fr)
AU (1) AUPN089295A0 (fr)
CA (1) CA2211450A1 (fr)
FI (1) FI973216A (fr)
NO (1) NO973548L (fr)
WO (1) WO1996023522A1 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU223205B1 (hu) 1996-12-03 2004-03-29 Zoltán Dárdai Helyileg alkalmazható készítmény peptidszerű gyógyhatású vegyületek élő szervezetbe vitelére
US20040037828A1 (en) 2002-07-09 2004-02-26 Bar-Ilan University Methods and pharmaceutical compositions for healing wounds
CA2416788A1 (fr) * 2000-07-31 2002-02-07 Tamar Tennenbaum Methodes et compositions pharmaceutiques comprenant des isoformes de la proteine kinase c utilisees pour le traitement de plaies
EP1651161B1 (fr) 2003-08-07 2011-10-19 HealOr Ltd. Compositions pharmaceutiques et methodes permettant d'accelerer la cicatrisation de plaies
EP2077132A1 (fr) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispositif distributeur, dispositif de stockage et procédé pour la distribution d'une formulation
EP2662472B1 (fr) 2009-03-31 2019-02-27 Boehringer Ingelheim International Gmbh Procédé de revêtement d'une surface d'un composant
US9265910B2 (en) 2009-05-18 2016-02-23 Boehringer Ingelheim International Gmbh Adapter, inhalation device, and nebulizer
JP5658268B2 (ja) 2009-11-25 2015-01-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
EP2504052B1 (fr) 2009-11-25 2022-07-27 Boehringer Ingelheim International GmbH Nébuliseur
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
EP2585151B1 (fr) 2010-06-24 2018-04-04 Boehringer Ingelheim International GmbH Nébuliseur
WO2012074989A2 (fr) * 2010-11-30 2012-06-07 Joslin Diabetes Center, Inc. Compositions et méthodes de traitement de troubles nerveux associés au diabète
EP2694220B1 (fr) 2011-04-01 2020-05-06 Boehringer Ingelheim International GmbH Appareil médical pourvu d'un récipient
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (fr) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Pulvérisateur comprenant des moyens de détrompage
EP3030298B1 (fr) 2013-08-09 2017-10-11 Boehringer Ingelheim International GmbH Nébuliseur
ES2836977T3 (es) 2013-08-09 2021-06-28 Boehringer Ingelheim Int Nebulizador
RS64124B1 (sr) 2014-05-07 2023-05-31 Boehringer Ingelheim Int Inhalator i kontejner
DK3139984T3 (da) 2014-05-07 2021-07-19 Boehringer Ingelheim Int Forstøver
ES2954961T3 (es) 2014-05-07 2023-11-27 Boehringer Ingelheim Int Unidad, nebulizador y método

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4136685A (en) * 1984-04-18 1985-10-24 Geriaco A.G. Product for the treatment of acne vulgaris
WO1985005036A1 (fr) * 1984-04-30 1985-11-21 The Trustees Of Columbia University In The City Of Traitement topique du diabete a l'aide d'insuline et d'un agent ameliorant la penetration applique sur la peau et recouvert d'une pastille
DD254881A1 (de) * 1986-10-29 1988-03-16 Univ Dresden Tech Nicht parenteral anwendbares insulinpraeparat mit verzoegerter wirkung
US5145679A (en) * 1989-10-05 1992-09-08 Hinson Joan B Topical emollient for prevention and treatment of circulatory induced lesions
JPH04149126A (ja) * 1990-10-09 1992-05-22 Mitsubishi Kasei Corp 経粘膜投与用医薬組成物
DE4208552A1 (de) * 1992-03-17 1993-09-23 Liedtke Pharmed Gmbh Topische arzneiformen mit insulin
FR2710530B1 (fr) * 1993-09-29 1995-12-22 Phedon Zirinis Gel aqueux à usage nasal, pellets, et leur procédé de préparation.
FR2710529A1 (fr) * 1993-09-29 1995-04-07 Zirinis Phedon Gel aqueux à usage nasal, pellets, et leur procédé de préparation.

Also Published As

Publication number Publication date
NO973548L (no) 1997-10-02
EP0808170A1 (fr) 1997-11-26
AUPN089295A0 (en) 1995-03-02
JPH11502513A (ja) 1999-03-02
NO973548D0 (no) 1997-08-01
MX9705920A (es) 1998-06-28
WO1996023522A1 (fr) 1996-08-08
FI973216A (fi) 1997-10-01
FI973216A0 (fi) 1997-08-04
KR19980701896A (ko) 1998-06-25

Similar Documents

Publication Publication Date Title
CA2211450A1 (fr) Traitement de la neuropathie diabetique
Poyer et al. Prostaglandin F2 alpha effects on isolated rhesus monkey ciliary muscle.
Rehman et al. Use of intralesional verapamil to dissolve Peyronie’s disease plaque: a long-term single-blind study
US5411738A (en) Method for treating nerve injury pain associated with shingles (herpes-zoster and post-herpetic neuralgia) by topical application of lidocaine
Miller et al. The release of PGE2-like activity into aqueous humor after paracentesis and its prevention by aspirin
Rowbotham et al. Topical lidocaine reduces pain in post-herpetic neuralgia
NO323573B1 (no) Preparat inneholdende minst ett strontiumsalt, et aktivt middel, og minst ett middel valgt fra et hydrofilt middel og/eller et lipofilt middel og/eller et termal- eller mineralvann.
CA2180454A1 (fr) Preparation dermoprotectrice d'usage externe
JP2000512996A (ja) 皮膚感作および刺激の予防および治療措置
EP1613334A2 (fr) Composition a base d'insuline pour administration transdermique, sans alcool, et procedes de production et d'utilisation associes
Camras et al. Inhibition of the epinephrine-induced reduction of intraocular pressure by systemic indomethacin in humans
CA2001797A1 (fr) Onguent topique pour les dermatoses
US20030181515A1 (en) Methods of using kavalactone compositions
JPH08505388A (ja) ヒアルロン酸−尿素医薬組成物およびその使用
Weinreb et al. A double-masked three-month comparison between 0.25% betaxolol suspension and 0.5% betaxolol ophthalmic solution
EP3137084B1 (fr) Amiloride de benzyle pour le traitement du psoriasis
LAMAR et al. Pityriasis rubra pilaris
RU2538696C2 (ru) Лечение дискомфорта глаз путем местного применения охлаждающего агента на наружной поверхности века
US20220265687A1 (en) Di-Isopropyl-Phosphinoyl -Alkanes as topical agents for the treatment of sensory discomfort
Nishihata et al. Clinical investigation of sodium diclofenac sustained-release suppositories
US20200360317A1 (en) Carboxylic acids for treating/preventing a skin disease
KR20180126908A (ko) 눈의 광반사(light reflectance)를 증가시키는 방법
JP3689137B2 (ja) アレルギー性皮膚疾患治療用外用剤
MXPA97005920A (en) Treatment of neuropathy diabet
Novack et al. Plasma levobunolol levels following topical administration with reference to systemic side effects

Legal Events

Date Code Title Description
FZDE Discontinued